Myriad Genetics, Inc. · NASDAQ:MYGN

BlackRock Portfolio Management LLC reported a 10.40% stake in Myriad Genetics, Inc. (Schedule 13G)

Event Aug 31, 2026 · Filed Sep 4, 2026

BlackRock Portfolio Management LLC reported a 10.40% stake in Myriad Genetics, Inc., 9,900,937 shares, as a passive investor on Aug 31, 2026. Filed Sep 4, 2026 (Schedule 13G).

Stake
10.40%
Shares
9,900,937
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock Portfolio Management LLC10.40%9,900,937

Source

View original at SEC

Related